Interviews with the world’s key opinion leaders in cancer

Tagoncology research

Rebecca Dent MD: ESMO Previous Highlights: Neo-Adjuvant Therapy for Triple Negative Breast Cancer, Checkpoint Inhibition, AI, Cancer Vaccines, and More ……

9 months ago

An interview with Rebecca Dent MD, Deputy Chief Executive Officer, National Cancer Centre, Singapore, ESMO 2024 Scientific Chair. ESMO Previous...

December 14, 2007

AudioMedica News Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide Play Episode Pause Episode 1x 00:00 / Subscribe RSS...